Real-time enrollment status for this neuroblastoma recurrent clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 7:39 PM UTC
| NCT Number | NCT07085338 |
| Recruiting Status | Recruiting |
| Condition | Neuroblastoma Recurrent |
| Phase | PHASE2 |
| Target Enrollment | 54 participants |
| Active Locations | 5 sites in the US |
| Sponsor | St. Jude Children's Research Hospital |
| Last Updated on CT.gov | August 7, 2026 (3 weeks ago) |
As of August 29, 2026: Clinical trial NCT07085338 is currently recruiting participants. This phase2 study for neuroblastoma recurrent is actively seeking new participants at 5 locations across the United States. The study is sponsored by St. Jude Children's Research Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07085338 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07085338 was last updated 3 weeks ago (August 7, 2026). HelloStudys verifies this status automatically.